MARKET OPPORTUNITY

A primary indicator of the HSV-2 market potential is the HPV market.

Merck's Gardasil is the leading product with sales of over $3 billion in 2018.

HPV Market Demonstrates the HSV2 Opportunity

Human Papillomavirus Vaccine Global Market - Sales (1)

2019:                               $ 3.80 billion

 

2027 Estimate:                $12.69 billion

 

CAGR 2020-2027              16.30 % 

(1) FortuneBusinessInsights.com/human-papillomavirus-hpv-vaccines-market-101962  08/20